Table 4. Lung cancer incidence rate ratios1 for all lung cancers and histologic cell-types by Hispanic ethnic enclave for Hispanic males and females, California 2008–2012.
| Male | Female | ||||||
|---|---|---|---|---|---|---|---|
| Ethnic enclave | Cases | IRR2 | (95% CI2) | Cases | IRR | (95% CI) | |
| Overall lung cancer | Q4-high | 1953 | 1.00 | reference | 1440 | 1.00 | reference |
| Q3 | 1257 | 1.02 | (0.95, 1.10) | 1141 | 1.25 | (1.15, 1.35) | |
| Q2 | 744 | 1.07 | (0.97, 1.17) | 805 | 1.50 | (1.37, 1.63) | |
| Q1-low | 452 | 1.14 | (1.02, 1.27) | 503 | 1.64 | (1.48, 1.82) | |
| Adenocarcinoma | Q4-high | 801 | 1.00 | reference | 767 | 1.00 | reference |
| Q3 | 569 | 1.14 | (1.01, 1.27) | 600 | 1.23 | (1.10, 1.37) | |
| Q2 | 330 | 1.18 | (1.02, 1.35) | 446 | 1.56 | (1.38, 1.76) | |
| Q1-low | 197 | 1.24 | (1.05, 1.46) | 271 | 1.64 | (1.42, 1.89) | |
| SCC2 | Q4-high | 430 | 1.00 | reference | 197 | 1.00 | reference |
| Q3 | 276 | 1.02 | (0.87, 1.19) | 174 | 1.42 | (1.15, 1.76) | |
| Q2 | 165 | 1.03 | (0.85, 1.24) | 110 | 1.49 | (1.17, 1.90) | |
| Q1-low | 111 | 1.20 | (0.96, 1.49) | 63 | 1.58 | (1.17, 2.11) | |
| SCLC2 | Q4-high | 237 | 1.00 | reference | 149 | 1.00 | reference |
| Q3 | 114 | 0.72 | (0.56, 0.91) | 116 | 1.17 | (0.90, 1.50) | |
| Q2 | 83 | 0.96 | (0.73, 1.25) | 89 | 1.56 | (1.18, 2.05) | |
| Q1-low | 38 | 0.73 | (0.49, 1.04) | 52 | 1.68 | (1.19, 2.32) | |
| LC+OSC2 | Q4-high | 165 | 1.00 | reference | 128 | 1.00 | reference |
| Q3 | 117 | 1.26 | (0.97, 1.63) | 117 | 1.48 | (1.13, 1.93) | |
| Q2 | 51 | 0.89 | (0.62, 1.24) | 68 | 1.43 | (1.04, 1.95) | |
| Q1-low | 41 | 1.42 | (0.97, 2.03) | 51 | 1.93 | (1.35, 2.70) | |
| Unspecified | Q4-high | 320 | 1.00 | reference | 199 | 1.00 | reference |
| Q3 | 181 | 0.88 | (0.72, 1.07) | 134 | 1.06 | (0.84, 1.34) | |
| Q2 | 115 | 1.01 | (0.8, 1.27) | 92 | 1.23 | (0.95, 1.59) | |
| Q1-low | 65 | 0.96 | (0.71, 1.27) | 66 | 1.53 | (1.13, 2.04) | |
1. Bold type indicates statistical significance
2. IRR, incidence rate ratio; CI, confidence interval; SCC, squamous cell carcinoma; SCLC, small cell lung cancer; LC+OSC, large cell and other cell lung cancer